InsiderClue
← All stocks

Niagen Bioscience, Inc.

NAGE Net buying
CIK 0001386570 #3766 in the set updated 21 Sep 2026
Bought (12 mo)
$45.62K
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
+$45.62K
+$45.62K against sales at will

By person

4 insiders · 3 transactions
11.2×

Robert Fried holds 11.2 times base salary in stock. $7.26M of shares against $645.96K in salary for 2025.

Salary from the company's own proxy. The shares are what Robert Fried last reported holding, valued at $6.85, the price Common Stock was last bought or sold at on the open market here, on 14 Nov 2025.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Pamir Ozan
Chief Financial Officer
$45.62K (2)
—
+$45.62K
13,848
0.0175%
$94.86K
—
Fried Robert N
Chief Executive Officer
—
—
—
1,060,087
1.34%
$7.26M
+9.0%
Jaksch Frank L Jr
Director
—
—
—
244,179
0.3086%
$1.67M
+5.6%
Lopez Carlos Luis
SVP, General Counsel
—
—
—
4,565
0.0058%
$31.27K
+130.8%

Individual transactions

3
Insider
Date
Role
Action
Shares
Price
Amount
Fried Robert N
24 Apr 2026
Chief Executive Officer
Exercised, kept
20,000
$2.61
$52.20K
Pamir Ozan
14 Nov 2025
Chief Financial Officer
Buy indirect
2,220
$6.85
$15.21K
Pamir Ozan
14 Nov 2025
Chief Financial Officer
Buy
4,465
$6.81
$30.41K

What was left out

Form 4 filings counted 15
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 27,675
History held since 2 Sep 2016